Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP167314.RAK76EyEvpYqkas8kv-vgRk5o-1CpOjf8IzZzoIrE2EUk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP167314.RAK76EyEvpYqkas8kv-vgRk5o-1CpOjf8IzZzoIrE2EUk130_assertion type Assertion NP167314.RAK76EyEvpYqkas8kv-vgRk5o-1CpOjf8IzZzoIrE2EUk130_head.
- NP167314.RAK76EyEvpYqkas8kv-vgRk5o-1CpOjf8IzZzoIrE2EUk130_assertion description "[The median survival from diagnosis of prostate cancer was 4.0 years for men with a BRCA2 mutation vs 8.0 years for men with a BRCA1 mutation, and the difference was highly significant.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP167314.RAK76EyEvpYqkas8kv-vgRk5o-1CpOjf8IzZzoIrE2EUk130_provenance.
- NP167314.RAK76EyEvpYqkas8kv-vgRk5o-1CpOjf8IzZzoIrE2EUk130_assertion evidence source_evidence_literature NP167314.RAK76EyEvpYqkas8kv-vgRk5o-1CpOjf8IzZzoIrE2EUk130_provenance.
- NP167314.RAK76EyEvpYqkas8kv-vgRk5o-1CpOjf8IzZzoIrE2EUk130_assertion SIO_000772 18577985 NP167314.RAK76EyEvpYqkas8kv-vgRk5o-1CpOjf8IzZzoIrE2EUk130_provenance.
- NP167314.RAK76EyEvpYqkas8kv-vgRk5o-1CpOjf8IzZzoIrE2EUk130_assertion wasDerivedFrom lhgdn-20090331 NP167314.RAK76EyEvpYqkas8kv-vgRk5o-1CpOjf8IzZzoIrE2EUk130_provenance.
- NP167314.RAK76EyEvpYqkas8kv-vgRk5o-1CpOjf8IzZzoIrE2EUk130_assertion wasGeneratedBy ECO_0000203 NP167314.RAK76EyEvpYqkas8kv-vgRk5o-1CpOjf8IzZzoIrE2EUk130_provenance.